| 中文 | 英文 | 栏目 |
|---|---|---|
| 首页 | Home | Home |
| 关于以岭 | About Yiling | About Yiling |
| 以岭概况 | Overview of Yiling | Overview |
| 创始人介绍 | Introduction of Founder | Founder Introduction |
| 董事长介绍 | Introduction of Chairman | Chairman Introduction |
| 荣誉殿堂 | Hall of Fame | Hall of Fame |
| 企业文化 | Corporate Culture | Corporate Culture |
| 以岭动态 | Yiling Dynamics | Company News |
| 公司要闻 | Company Highlights | Company Highlights |
| 视频中心 | Video Center | Video Center |
| 以岭公益 | Yiling Public Welfare | Public Welfare |
| 产品展示 | Product Display | Product Display |
| 创新中药 | Innovative Chinese Medicine | Innovative Chinese Medicine |
| 化药系列 | Chemical Series | Chemical Series |
| 健康产品 | Health Products | Health Products |
| 配方颗粒 | Granulated Formula | Granulated Formula |
| 投资者关系 | Investor Relations | Investor Relations |
| 基本概况 | Basic Overview | Basic Overview |
| 公司公告 | Company Announcements | Company Announcements |
| 年度报告 | Annual Report | Annual Report |
| 社会责任报告 | Social Responsibility Report | Social Responsibility Report |
| 加入我们 | Join Us | Join Us |
| 人才理念 | Talent Philosophy | Talent Philosophy |
| 校园招聘 | Campus Recruitment | Campus Recruitment |
| 社会招聘 | Social Recruitment | Social Recruitment |
| 联系我们 | Contact Us | Contact Us |
| 安全性信息反馈 | Safety Information Feedback | Safety Information Feedback |
| 企业 OA | Enterprise OA | Enterprise OA |
| 企业邮箱 | Enterprise Email | Enterprise Email |
| EHR | Electronic Health Record | Electronic Health Record |
| 了解更多 | Learn More | Learn More |
| 查看更多动态 | View More Dynamics | View More Dynamics |
| 通心络治疗急性心梗研究位列2023年度中医药十大学术进展首位 | Tongxinluo Treatment of Acute Myocardial Infarction Ranked First in the Top Ten Academic Progress of Traditional Chinese Medicine in 2023 | Tongxinluo Treatment of Acute Myocardial Infarction Ranked First in the Top Ten Academic Progress of Traditional Chinese Medicine in 2023 |
| 【以岭论坛】聚焦冠状动脉口部病变精准介入诊疗，提升心血管病中西医结合治疗水平 | [Yiling Forum] Focusing on Precise Intervention Diagnosis and Treatment of Coronary Artery Orifice Lesions, Enhancing the Level of Cardiovascular Disease Treatment by Integrating Traditional Chinese Medicine and Western Medicine | [Yiling Forum] Focusing on Precise Intervention Diagnosis and Treatment of Coronary Artery Orifice Lesions, Enhancing the Level of Cardiovascular Disease Treatment by Integrating Traditional Chinese Medicine and Western Medicine |
| 以岭药业制剂车间获评“全国工人先锋号” | Yiling Pharmaceutical Preparation Workshop Awarded “National Pioneer of Workers” | Yiling Pharmaceutical Preparation Workshop Awarded “National Pioneer of Workers” |
| 以岭药业：十万亩连翘种植基地成为村民致富“黄金钥匙” | Yiling Pharma: 100,000 Mu of Forsythia Planting Base Becomes the “Golden Key” to Villagers’ Wealth | Yiling Pharma: 100,000 Mu of Forsythia Planting Base Becomes the “Golden Key” to Villagers’ Wealth |
| 中华通络操在“四川-首尔文化旅游交流会”上大放异彩 | Zhonghua Tongluo Exercise Shines at the “Sichuan-Seoul Cultural and Tourism Exchange Conference” | Zhonghua Tongluo Exercise Shines at the “Sichuan-Seoul Cultural and Tourism Exchange Conference” |
| 创立“五位一体”发展新模式 | Establishing a New Development Model of “Five in One” | Establishing a New Development Model of “Five in One” |
| 首次形成系统络病理论 | First Formulation of Systematic Collateral Disease Theory | First Formulation of Systematic Collateral Disease Theory |
| 六项国家成果奖 | Six National Achievement Awards | Six National Achievement Awards |
| 两次承担国家973项目 | Undertaking the National 973 Project Twice | Undertaking the National 973 Project Twice |
| 冀ICP备12020237号-5 | Hebei ICP Prepared No. 12020237-5 | Hebei ICP Prepared No. 12020237-5 |
| 河北以岭医院 | Hebei Yiling Hospital | Hebei Yiling Hospital |
| 以岭健康 | Yiling Health | Yiling Health |
| 疑难病杂志社 | Journal of Difficult and Complicated Diseases | Journal of Difficult and Complicated Diseases |
-
域名信息
注册人/机构：石家庄以岭药业股份有限公司
注册人邮箱：****8599@qq.com
域名年龄：19年1个月18天（过期时间为2025年03月10日)
-
备案信息
备案号：冀ICP备12020237号
名称：石家庄以岭药业股份有限公司
性质：企业
审核时间：2022-06-06
-
网站信息
IP：40.73.32.115[中国北京北京 微软云]
排行
全球排名
#273342
全世界
国家排名
#15203
中国
类别排名
#N/A
访问次数
- 预估流量
跳出率
12.71%
每次访问的页数
4.17
每月访问量
14.300 万
平均访问时长
00:02:22
热门关键词
- 全球
- 桌面端
关键词
自然
搜索量
北京以岭药业主要生产什么
112.00
0.00
--
北京以岭药业
112.00
0.00
--
以岭药业官网
123.00
0.00
--
以岭药业
1.84 千
800.00
--
以岭
1.00
90.00
--
国家&地区分布图
- 仅限桌面
排名前 5 的国家 & 地区
国家 & 地区
美国
4.95%
香港
0.03%
中国
95.02%
流量来源
- 全球
- 仅限桌面端
流量占比图表
来源
Direct
61.67%
Search
34.36%
Referrals
2.69%
Paid Referrals
0.75%
Social
0.48%
Mail
0.05%
数据统计
数据评估
关于以岭药业特别声明
本站血鸟导航提供的以岭药业相关数据内容都来源于网络或站长收集，不保证外部链接和内容的准确性和完整性，同时，对于该外部链接的指向，不由血鸟导航实际控制，在2024年5月8日 上午11:55收录时，该网页上的内容，都属于合规合法，后期网页的内容如出现违规或不对称，欢迎联系我们邮箱进行删除或更改，血鸟导航不承担任何责任。
相关导航
暂无评论...
XieNiao 血鸟导航，集网址、资源、资讯于一体的定制化导航主题，简约优雅的设计风格，自定义网址的用户功能，自定义主页，欢迎您的体验
赣公网安备36020002000448号